期刊文献+

人副流感病毒3型HN糖蛋白N-糖链的功能研究 被引量:3

Study on Functions of N-Carbohydrate Chains in Human Parainfluenza Virus Type 3 Hemagglutinin-Neuraminidase Protein
原文传递
导出
摘要 为了研究人副流感病毒3型(hPIV3)HN糖蛋白N-糖链的功能,采用基因定点突变技术构建糖基化位点突变体,然后检测各突变株的蛋白电泳速率、细胞表面表达量、受体结合活性、神经氨酸酶活性和促细胞融合活性。HN分子的G1、G2、G3和G4 4个糖基化位点分别和联合突变后发现G1、G2和G4及其联合突变株(G12、G14、G24和G124)电泳速率加快,而G3突变株电泳速率没有变化。各突变株的表达效率,神经氨酸酶活性与野毒株相比差别无统计学意义(P>0.05),但受体结合活性和促细胞融合活性均有不同程度的降低(P<0.05)。G1、G2和G4位点突变后受体结合活性分别为突变前的83.94%、76.45%和55.32%,而促细胞融合活性降为突变前的80.84%、77.83%和64.16%。联合突变株G12、G14、G24和G124血吸附活性进一步降低,为突变前的33.07%、20.67%、19.96%和15.11%,促细胞融合活性进一步降低为突变前的46.36%、12.04%、13.43%和4.05%。结果表明:hPIV3HN糖蛋白的糖链对HN糖蛋白的受体结合活性和促细胞融合活性有重要影响,推断糖链的丢失可能会引起HN糖蛋白头部结构(受体结合活性位点所在区域)或者方向的改变或者无法与宿主细胞膜表面的凝集素受体(一种与N-糖链结合的受体)结合,进而导致受体结合活性和促细胞融合活性的降低。 To determine the functions of N-carbohydrate chains in human parainfluenza virus type 3 hemag- glutinin-neuraminidase(HN) protein, a PCR-based site-directed mutagenesis method was used to obtain N- glycan mutants. Protein electrophoresis rate, cell surface expression,receptor binding activity, neuramini- dase activity and cell fusion promotion activity were determined. The HN proteins of single mutants (G1, G2, and G4) and multiple mutants (G12, G14, G24 and G124) migrated faster than the wild-type (wt) HN protein on polyacrylamide gels, while G3-mutated protein and wt HN protein migrated at the same po- sition. There was no statistic difference in cell surface expression and neuraminidase activity between wt and each mutant HN protein (P^0.05), but receptor binding activity and cell fusion promotion activity of each mutant protein was reduced to significant extent (P〈0.05). G1, G2 and G4 mutants exhibited re- duced receptor binding activity, which was 83. 94%, 76.45% and 55.32% of the wt level, respectively. G1, G2 and G4-mutated proteins also showed reductions in fusion promotion activity, which was 80.84%, 77.83% and 64.16%, respectively. Multiple mutants with G12-, G14-, G24- and G124- substitutions could further reduce receptor binding activities, 33.07%, 20.67%, 19.96% and 15.11G of the wt HN level, respectively. G12, G14, G24 and G124 mutants exhibited levels of fusion promotion activity that were only 46.36%, 12.04%, 13.43% and 4.05% of the wt amount, respectively. As N-glycans of hPIV3 HN protein play an important role in receptor binding activity and cell fusion promotion activity of HN protein. We propose that the loss of N-glycans change the conformation or orientation of globular domain that is responsible for receptor binding and lower receptor binding activity and cell fusion promotion activity.
出处 《病毒学报》 CAS CSCD 北大核心 2013年第5期500-508,共9页 Chinese Journal of Virology
基金 国家自然科学基金(30970142和81271806) 山东大学创新团队资助项目 山东省自然科学基金(2009ZRB019VW) 中国博士后科学基金(20090461219)
关键词 副流感病毒3型 HN蛋白质 细胞融合 血细胞吸附 神经氨酸酶 Human parainfluenza virus type 3 HN protein Cell fusion Hemadsorption Neuraminidase
  • 相关文献

参考文献21

  • 1Fry A M, Curns A T, Harbour K, et al. Seasonal trends of human parainfluenza viral infections: United States, 1990-2004 [J]. Clin Infect Dis, 2006, 43 (8): 1016-1022.
  • 2Zhan X, Siobod K S, Krishnamurthy S, et al. Sendai virus recombinant vaccine expressing hPIV-3 HN or F elicits protective immunity and combines with a second recombinant to prevent hPIV-1, hPIV-3 and RSV infections [J]. Vaccine, 2008, 26(27-28): 3480-3488.
  • 3Palermo L M, Porotto M, Greengard O, et al. Fusion promotion by a paramyxovirus hemagglutinin-neuraminidase protein: p H modulation of receptor avidity of binding sites I and II [J]. J Virol, 2007, 81 (7): 9152- 9161.
  • 4Dutch R E, Joshi S B, Lamb R A, et al. Membrane fusion promoted by increasing surface densities of the paramyxovirus F and HN proteins: comparison of fusion reactions mediated by simian virus 5 F, human parainfluenza virus type 3 F, and influenza virus HA [J]. J Virol, 1998, 72(0): 7745-7753.
  • 5Tanaka y, Kato J, Kohara M, et al. Antiviral effects of glycosylation and glucose trimming inhibitors on human parainfluenza virus type 3 [J]. Antiviral Res, 2006, 72(1):1-9.
  • 6Bose S, Basu M, Banerjee A K, et al. Role of nucleolin in human parainfluenza virus type 3 infection of human lung epithelial cells [J]. J Virol, 2004, 78(5): 8146- 8158.
  • 7Levroney E L, Aguilar H C, Fulcher J A, et al. Novel innate immune functions for galectin-L, galectin-l inhibits cell fusion by Nipah virus envelope glycoproteins and augments dendritic cell secretion of proinflammatory cytokines [J]. J Immunol , 2005, 175 (1): 413-420.
  • 8Bagai S, Lamb R A. Quantitative measurement of paramyxovirus fusion: differences in requirements of glycoproteins between simian virus 5 and human parainfluenza virus 3 or Newcastle disease virus [J]. J Virol , 1995,69(1): 6712-6719.
  • 9Zhang W, Ren G, Wu B, et al. Amino acid substitutions in leucine zipper motif in the F-specific domain of human parainfluenza virus 3 HN protein play important roles in the protein function [J]. Intervirology, 2008, 51(5): 311-321.
  • 10Wang Z, Mirza A M, Li J, et al. An oligosaccharide at the C-terminus of the F-specific domain in the stalk of the human parainfluenza virus 3 hemagglutinin neuraminidase modulates fusion [J]. Virus Res, 2004, 99(2): 177-185.

同被引文献55

  • 1任桂杰,王志玉.副粘病毒包膜糖蛋白分子生物学研究进展[J].病毒学报,2005,21(1):72-75. 被引量:15
  • 2Henrickson KJ. Parainfluenza Viruses [ J ]. Clin Microbiol Rev, 2003, 16(2) : 242-264.
  • 3Takimoto T, Taylor GL, Connaris HC, et al. Role of the hemag- glutinin-neuraminidase protein in the mechanism of paramyxovirus- cell membrane fusion[J]. J Virol, 2002, 6(24) : 13028-13033.
  • 4Schmidt AC, Schaap-Nutt A, Bartlett E J, et al. Progress in the development of human parainfluenza virus vaccines [ J 1- Expert Rev Resoir Med. 2011. 5(4) : 515-526.
  • 5Falsey AR. Current management of paraintluenza pneumonitis in immunocompromised patients : a review ~ J ]. Infect Drug Resist, 2012, 5 : 121-127.
  • 6Weinberg GA, Hall CB, Iwane MK, et al. Parainfluenza virus infection of young children: estimates of the population-based burden of hospitalization [ J ]. J Pediatr, 2009, 154 (5) : 694- 699.
  • 7Brown DM. Cytolytic CIM cells: Direct mediators in infectious disease and malignancy[J]. Cell Immunol, 2010, 262(2) : 89- 95.
  • 8Le Nou~n C, Hillyer P, Munir S, et al. Effects of human respir- atory syncytial virus, metapneumovirus, parainfluenza virus 3 and influenza viru son CIM T cell activation by dendritic cells[ J]. PLoS One, 2010, 5(11) : e15017.
  • 9Karron RA, Makhene M, Gay K, et al. Evaluation of a live at- tenuated bovine parainfluenza type 3 vaccine in two- to six-month- old infants[J]. Pediatr Infect Dis J, 1996, 15(8) : 650-654.
  • 10Greenberg DP, Walker RE, Lee MS, et al. A bovine parainflu- enza virus type 3 vaccine is safe and immunogenic in early infan- cy[J]. J Infect Dis, 2005, 191 (7) : 1116-1122.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部